Across TCGA pan-cancer cohorts, B3GALT5-AS1 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated B3GALT5-AS1 data layer compared with 17 for mass-spec protein.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher B3GALT5-AS1 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated B3GALT5-AS1 expression acts as an unfavorable survival marker.

COAD and ESCA are the cancer types where B3GALT5-AS1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Median	All	0.111	0.871	<.001	12	view →
ESCA	OS	Median	II,III,IV	0.321	0.685	.035	6	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: B3GALT5-AS1 tumor-vs-normal RNA expression · all B3GALT5-AS1 data types